A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)

Name: A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)
Published: 2008
License: Public Domain

Janssen Pharmaceutical K.K. · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

multiple-myeloma

multiple myeloma, hematopoietic stem cell transplant, hsct, melphalan, prednisolone, bortezomib, jnj-26866138, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)

Related documents